Showing 841-850 of 5060 results for "".
Better Brow Lifts
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/better-brow-lifts/18302/An effective neuromodulator brow lift depends on identifying two key points that will help determine the ideal injection location, says Joel L. Cohen, MD, a dermatologist in Greenwood Village, CO. The key is to inject the orbicularis oculi only and to avoid the frontalis entirely. Dr. Cohen is co-ed2017 Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/2017-tax-cuts-and-jobs-act-what-you-need-to-know--vmyiwowa/18348/OJM Group principal Carole Foos, CPA provides an overview of the Tax Cuts and Jobs Act, which was signed in to law at the end of 2017. She discusses key provisions affecting individual physicians and medical practices, and offers advice to consider when planning for 2018 and beyond. Click here to reImproving Outcomes with Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-outcomes-with-fillers/18740/For the most optimal outcomes when injecting fillers, Dr. Galadari says there are three essential steps: choose the right patient, choose the right filler, and choose the right injection technique. He shares his favorite types of fillers for specific areas and discusses when and why he uses a cannulPapa in at Valeant, J&J Acquires Neostrata, Celebrity Lip Envy
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-papa-in-at-valeant-j-j-acquires-neostrata-celebrity-lip-envy/18772/This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation arouSRT100: Innovating Topical Radiation Therapy for Skin Cancers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/srt100-innovating-topical-radiation-therapy-for-skin-cancers/19041/The United States has become one of the chief areas of non-melanoma as well as melanoma skin cancer. One of the first treatments that was invented by dermatologists has been the use of radiation therapy for skin cancer. George Miller McKee, who is the father of many of the treatments of both melanoRestylane Lyft Approved, Analyzing New Quality of Life Data
https://practicaldermatology.com/series/dermwire-tv/dermwire-restylane-lyft-approved-analyzing-new-quality-of-life-data--ibalorid/18878/Restylane Lyft from Galderma approved for mid face volume enhancement, New data analyzes significance of patient quality of life in diseases like psoriasis and atopic dermatitis, Merz North America establishes new headquarters in Raleigh, NC, and Boston unveils free sunscreen dispensers.Radiesse for Hands, Alevicyn Cleared
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-radiesse-for-hands-alevicyn-cleared/18898/Merz gets FDA approval for Radiesse for hand augmentation and releases data comparing Xeomin to Botox. Heidi Waldorf, MD, FAAD and Michael Gold, MD, FAAD, comment. Also in this edition, Galderma participate in a White House forum on antibiotic stewardship, and the FDA gives 510(k) clearance to AleviImplementing Skincare Solutions in Practice
https://practicaldermatology.com/topics/practice-management/implementing-skincare-solutions-in-practice/18902/Leslie Baumann, MD, FAAD discusses the challenges of offering effective skincare recommendations to patients and shares some of the practical solutions she has implemented in her practice. The author of "The Skin Type Solution," describes how she chooses skincare for each individual patient and giveMy Dermatology Wish List
https://practicaldermatology.com/topics/practice-management/my-dermatology-wish-list/18911/What is Dr. Bill Ju's wish for dermatology? The President of Advancing Innovation in Dermatology wants to continue to grow entrepreneurship as a grassroots effort. He'd like to see more support for young ideas and young thinkers.Kythera's Kybella Approved; ASLMS Update
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-kythera-s-kybella-approved-aslms-update/18925/FDA Approves Kythera's Kybella (ATX-101 or deoxycholic acid) injection for reduction of sub mental fullness or double chin. ASLMS Recognizes women in device-based medicine (Women in Energy-based Devices). Deka and Syneron get new clearances. ASDS Launches Skin Cancer PSAs, and Foamix sells shares.